標(biāo)題: Titlebook: Cell Therapy for Brain Injury; David C. Hess Book 2015 Springer International Publishing Switzerland 2015 adipose stem cells.brain repair. [打印本頁] 作者: SPARK 時(shí)間: 2025-3-21 16:07
書目名稱Cell Therapy for Brain Injury影響因子(影響力)
書目名稱Cell Therapy for Brain Injury影響因子(影響力)學(xué)科排名
書目名稱Cell Therapy for Brain Injury網(wǎng)絡(luò)公開度
書目名稱Cell Therapy for Brain Injury網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cell Therapy for Brain Injury被引頻次
書目名稱Cell Therapy for Brain Injury被引頻次學(xué)科排名
書目名稱Cell Therapy for Brain Injury年度引用
書目名稱Cell Therapy for Brain Injury年度引用學(xué)科排名
書目名稱Cell Therapy for Brain Injury讀者反饋
書目名稱Cell Therapy for Brain Injury讀者反饋學(xué)科排名
作者: 閑聊 時(shí)間: 2025-3-21 23:11
https://doi.org/10.1007/BFb0030998been with adult stroke, we also include chapters on the use of cell therapy in traumatic brain injury, neonatal stroke, and neonatal hypoxic–ischemic encephalopathy. While cell therapy has enormous potential to improve the quality of life of many with brain injury, the field has suffered from too mu作者: 棲息地 時(shí)間: 2025-3-22 01:43
https://doi.org/10.1007/BFb0034355uming that our understanding of the potential benefit of cell therapy in a therapeutic role can advance more in parallel with our technical capabilities for their utilization. The great promise of stem cell therapy to repair, replace, and/or redirect endogenous stem cells provides an exciting altern作者: 細(xì)絲 時(shí)間: 2025-3-22 07:43
https://doi.org/10.1007/BFb0034355regulations on stem cell use for clinical applications will be discussed, from bench (diverse cell sources and culture processes) to bedside (patient selection, blood-brain barrier manipulation, and outcome measures).作者: 財(cái)主 時(shí)間: 2025-3-22 09:54 作者: 上腭 時(shí)間: 2025-3-22 15:40 作者: 上腭 時(shí)間: 2025-3-22 18:28 作者: aggrieve 時(shí)間: 2025-3-22 22:47 作者: 數(shù)量 時(shí)間: 2025-3-23 04:35 作者: 不整齊 時(shí)間: 2025-3-23 08:55 作者: 紅潤 時(shí)間: 2025-3-23 12:43
Optimal control of heating processes,as prompted investigation in many different disease models of conditioned medium (CM) obtained from culturing MSC. Seminal studies in rodent stroke models have validated the therapeutic potential of adipose stem/stromal cell (ASC) as well as MSC-CM, demonstrating a similar effect as with cell delive作者: Flounder 時(shí)間: 2025-3-23 14:21 作者: Arthr- 時(shí)間: 2025-3-23 20:16 作者: 變化 時(shí)間: 2025-3-24 00:47 作者: 整潔漂亮 時(shí)間: 2025-3-24 02:21
Autologous Mesenchymal Stem Cell Therapy in Patients with Stroke,regulations on stem cell use for clinical applications will be discussed, from bench (diverse cell sources and culture processes) to bedside (patient selection, blood-brain barrier manipulation, and outcome measures).作者: chapel 時(shí)間: 2025-3-24 08:13
,Clinical Development of MultiStem? for Treatment of Injuries and Diseases of the Central Nervous Syntrolled phase I/II trial evaluating cell safety and efficacy in patients suffering an acute ischemic stroke. Aspects of the trial design and exploratory endpoints were developed as a function of preclinical animal testing with multiple different collaborative laboratories. A hypothesis emerged base作者: 圣歌 時(shí)間: 2025-3-24 10:49
Intra-arterial Approaches to Stem Cell Therapy for Ischemic Stroke, attributes including minimally invasive and targeted delivery of cells to area of brain injury. This route of delivery of cells has been the focus of our laboratory and here we review the preclinical data and the recent rise in published early clinical trials of cell-based therapy in ischemic strok作者: 英寸 時(shí)間: 2025-3-24 16:54
Induced Pluripotent Stem Cells as a Cell-Based Therapeutic in Stroke,development, choosing the optimal iPSC-derived neural progenitors to transplant, determining the ideal routes, timing, and doses of cell transplantation, and developing good manufacturing practices (GMP) to safely expand and maintain the cells for clinical use. While both autologous and allogeneic t作者: 芳香一點(diǎn) 時(shí)間: 2025-3-24 19:12 作者: palliate 時(shí)間: 2025-3-25 02:29
Preconditioning and Cell-Based Therapeutics,uch as stromal derived factor (SDF)-1 and erythropoietin also serve as “preconditioning” agents. Another approach is to “condition” the host tissue. A safe and feasible intervention, remote ischemic conditioning using a blood pressure cuff on the limbs, makes the host more receptive and responsive t作者: 確定的事 時(shí)間: 2025-3-25 03:28 作者: 勉勵(lì) 時(shí)間: 2025-3-25 07:47
A Stem-Cell-Derived Cell-Free Therapy for Stroke: Moving Conditioned Medium into Clinical Trial,as prompted investigation in many different disease models of conditioned medium (CM) obtained from culturing MSC. Seminal studies in rodent stroke models have validated the therapeutic potential of adipose stem/stromal cell (ASC) as well as MSC-CM, demonstrating a similar effect as with cell delive作者: avarice 時(shí)間: 2025-3-25 15:24 作者: legislate 時(shí)間: 2025-3-25 17:12 作者: 騎師 時(shí)間: 2025-3-25 23:25 作者: Control-Group 時(shí)間: 2025-3-26 00:36
https://doi.org/10.1007/BFb0034355gic deficits. Various cell types have been used to improve function and recovery after stroke, including embryonic stem cells, immortalized pluripotent stem cells, neural stem/progenitor cells, mononuclear cells, cell lines, and non-neuronal adult stem cells, such as mesenchymal stem cells (MSCs). T作者: PAC 時(shí)間: 2025-3-26 04:24 作者: Hearten 時(shí)間: 2025-3-26 11:25 作者: 一夫一妻制 時(shí)間: 2025-3-26 14:28 作者: 搖曳的微光 時(shí)間: 2025-3-26 18:12 作者: glacial 時(shí)間: 2025-3-27 00:21 作者: incision 時(shí)間: 2025-3-27 01:39 作者: admission 時(shí)間: 2025-3-27 07:37 作者: COST 時(shí)間: 2025-3-27 12:46
Optimal control of heating processes,nted cells can be increased by genetic modification or more easily by “preconditioning.” Preconditioning involves applying a sublethal stimulus to protect against a later lethal insult. One of the best-known and most feasible forms of preconditioning is “hypoxic preconditioning.” Stem cells normally作者: 滔滔不絕地講 時(shí)間: 2025-3-27 15:20 作者: 自愛 時(shí)間: 2025-3-27 19:45 作者: gratify 時(shí)間: 2025-3-27 23:08
Optimal control of heating processes,creasingly clear that the mechanism of action by which multipotent adult stem cells address the complex pathophysiology of stroke is not predominantly their ability to differentiate into cell types that replace tissues lost to injury, but occurs through factors secreted by these cells which promote 作者: Infraction 時(shí)間: 2025-3-28 03:56 作者: 環(huán)形 時(shí)間: 2025-3-28 07:50
Wil H. G. J. Hennen,D. W. de Hoopjury. The widespread use of stem cells for this purpose and others, despite the lack of strong clinical evidence for their efficacy in most clinical situations, makes it incumbent to review the pathophysiology of the clinical condition of neonatal HI brain injury, the preclinical data dealing with a作者: 思想流動(dòng) 時(shí)間: 2025-3-28 13:13
Experiences in decision support systems,re currently no evidence-based specific treatments for neonates with stroke. A growing number of studies have reported the benefits of cell-based therapies in rodent models of neonatal brain injury. However, the vast majority of evidence has come from studies in rodent models of hypoxia–ischemia, an作者: Kinetic 時(shí)間: 2025-3-28 17:45
https://doi.org/10.1007/BFb0040194ans. Evaluating such therapies in clinical trials introduces a number of complexities. Some of these are directly comparable to issues encountered in trials of acute stroke therapies, such as the need to stratify, train sites in endpoint measurement, and carefully select entry criteria in relation t作者: 出血 時(shí)間: 2025-3-28 19:39 作者: compel 時(shí)間: 2025-3-29 02:45
978-3-319-38099-5Springer International Publishing Switzerland 2015作者: 蟄伏 時(shí)間: 2025-3-29 03:47 作者: Duodenitis 時(shí)間: 2025-3-29 08:03 作者: exercise 時(shí)間: 2025-3-29 12:26 作者: allude 時(shí)間: 2025-3-29 15:43 作者: 四目在模仿 時(shí)間: 2025-3-29 21:43
media instead of cells, methods to enhance the potency of ceCell Therapy for Brain Injury is a thorough examination of using state-of-the-art cell therapy in the treatment of strokes and other traumatic brain injuries. This invaluable book covers this niche topic in depth from basic stem cell biolog作者: 機(jī)密 時(shí)間: 2025-3-30 02:08 作者: cardiopulmonary 時(shí)間: 2025-3-30 07:46 作者: Maximize 時(shí)間: 2025-3-30 09:27
Pathophysiology of Traumatic Brain Injury: Rationale and Role for Cellular Therapies,tial impact. This chapter will review the pathophysiology of traumatic brain injury, describe previous and current pre-clinical and clinical treatment strategies under investigation and discuss the role of cellular therapy.作者: Resistance 時(shí)間: 2025-3-30 12:55 作者: 易彎曲 時(shí)間: 2025-3-30 17:18 作者: Bravado 時(shí)間: 2025-3-30 21:38 作者: 用樹皮 時(shí)間: 2025-3-31 01:47 作者: Jogging 時(shí)間: 2025-3-31 08:38 作者: 反復(fù)拉緊 時(shí)間: 2025-3-31 11:39 作者: 離開就切除 時(shí)間: 2025-3-31 16:10 作者: 大暴雨 時(shí)間: 2025-3-31 20:24 作者: 錯(cuò)事 時(shí)間: 2025-3-31 23:50
Treatment of Autologous Bone Marrow Mononuclear Cells for Acute and Subacute Stroke,esearch findings regarding the link between angiogenesis and neurogenesis in the poststroke brain and outlines ongoing clinical trials using autologous bone marrow mononuclear cell transplantation for patients in the acute and subacute stage of stroke.作者: 運(yùn)動(dòng)吧 時(shí)間: 2025-4-1 03:01 作者: incarcerate 時(shí)間: 2025-4-1 08:26 作者: Substance-Abuse 時(shí)間: 2025-4-1 12:18 作者: tooth-decay 時(shí)間: 2025-4-1 14:39
Cell-Based Therapeutics in Stroke: An Industry Perspective,iled to confirm even a single neuroprotective agent for the treatment of this devastating disease. The solution for future drug development of stroke therapeutics must be truly transformational, considering less emphasis on animal models of neuroprotection, greater emphasis on mechanisms that are mo作者: 蛤肉 時(shí)間: 2025-4-1 18:58 作者: 出血 時(shí)間: 2025-4-2 01:32
